Evidence map›Paper›PMID 41598286›Full record

ArticleLife (Basel, Switzerland)2026

Anthocyanin Enhances Development, Hatching, and GLUT4 Expression in In Vitro-Cultured ICR Mouse Blastocysts.

Imran Khan, Yun Seok Heo

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Imran KhanAnimal Biotechnology Division, National Institute of Animal Science, Rural Development Administration, 1500 Kongjwipatjwi-ro, Wanju-gun 55365, Republic of Korea.ORCID 0000-0002-9228-1975
Yun Seok HeoDepartment of Mechanical & System Design Engineering, Hongik University, 94 Wausan-ro, Mapo-gu, Seoul 04066, Republic of Korea.ORCID 0000-0002-7038-4025

Funding

Regional Innovation System & Education (RISE);National Research Foundation of Korea (NRF);Hongik University new faculty research support fund 2025-RISE-01-035-05; No. RS- 2023-00252468
6 · The paper itself

Abstract

Anthocyanin is a flavonoid known for its strong antioxidant and anti-inflammatory activities in both in vitro and in vivo systems. This study investigated whether anthocyanin supplementation could improve the developmental competence, hatching rate, and the expression of development- and proliferation-related markers in ICR mouse blastocysts cultured in vitro. Mouse embryos were cultured in KSOM medium supplemented with 2, 4, or 8 μM anthocyanin. Among these, 4 μM was selected as the working concentration within the tested range. Morphological assessment was used to evaluate blastocyst development and hatching, while quantitative real-time polymerase chain reaction (qPCR) was performed to measure the expression of GLUT4 and PI3K. Anthocyanin supplementation significantly enhanced blastocyst quality, as reflected by higher developmental competence and increased hatching rates compared with the control group. In addition, anthocyanin-treated blastocysts displayed elevated mRNA expression of GLUT4 and PI3K, indicating a potential association with enhanced metabolic readiness and cellular proliferation. Overall, these findings indicate that anthocyanin supports embryo quality during preimplantation development in vitro, with potential relevance to implantation-related processes. Further research is needed to clarify the underlying mechanisms and explore the potential applications of anthocyanin in reproductive medicine.

Indexed as

anthocyanincell proliferationembryo developmentGLUT4implantation-related processesmouse blastocystsPI3K

Identifiers

PMID41598286
PMCPMC12842778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.